$35 Price Cap on Asthma Inhalers

Source: Asthma and Allergy Foundation of America

Some major asthma inhaler manufacturers announced $35 a month caps on out-of-pocket costs. The price cap will apply to people with commercial/private insurance (through your job or federal or state marketplace) or no insurance. At some pharmacies, the savings will be automatic. If your pharmacy doesn’t participate in the automatic savings, you can use a savings card to get the discount.

If you have government-funded insurance (such as Medicare, Medicaid, CHIP, or TRICARE), you won’t qualify fora price cap, but you may qualify for a patient assistance program that can reduce what you pay. The inhalers that will be price capped include:

• AstraZeneca: Airsupra, Bevespi Aerosphere, Breztri Aeosphere, and Symbicort

• Boehringer Ingelheim: Atrovent HFA, Combivent Respimat, Spiriva Handi Haler, Spiriva Respimat, And Striverdi Respimat.

• GSK: Advair Diskus, Advair FHA, Anora Ellipta, Amuity Ellipta, Breo Ellipta, Incruse Ellipta, Serevent Diskus, Trelegy Ellipta, and Ventalin HFA

How to save on GSK inhalers:

• If you have commercial insurance or no insurance: Download the GSK at: https://gskforyou.com/programs/gsk-coupons-free-trials/ and give it to your pharmacist.

• If you have government-funded insurance, such as Medicare, Medicaid, CHIP, or TRICARE: You may qualify for the GSK Patient Assistance Program for Anoro Ellipta, Arnuity Ellipta, Breo Ellipta, Incruse Ellipta, Serevent Diskus, and Trelegy Ellipta. Visit https://gskpaf.org/gsk/prescription-medicine-patient-assistance/ to see if you qualify.